Efficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience
Martin Huertas, R., Lopez Miranda, E., Corral de la Fuente, E., Serrano Domingo, J.J., Fernandez Abad, M., Martinez, N., Guerra, E.M., Cortes Salgado, A., Gion Cortes, M., Carrato Mena, A.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
de la Cruz-Merino, L, Gion, M, Cruz, J, Alonso-Romero, JL, Quiroga, V, Moreno, F, Andrés, R, Santisteban, M, Ramos, M, Holgado, E, Cortés, J, López-Miranda, E, Cortés, A, Henao, F, Palazón-Carrión, N, Rodriguez, L. M, Ceballos, I, Soto, A, Puertes, A, Casas, M, Benito, S, Chiesa, M, Bezares, S, Caballero, R, Jiménez-Cortegana, C, Sánchez-Margalet, V, Rojo, F
Published in BMC cancer (03.12.2022)
Published in BMC cancer (03.12.2022)
Get full text
Journal Article
Use of bevacizumab as a first-line treatment for metastatic breast cancer
Manso, L, Moreno, F, Márquez, R, Castelo, B, Arcediano, A, Arroyo, M, Ballesteros, A I, Calvo, I, Echarri, M J, Enrech, S, Gómez, A, González Del Val, R, López-Miranda, E, Martín-Angulo, M, Martínez-Jañez, N, Olier, C, Zamora, P
Published in Current oncology (Toronto) (01.04.2015)
Published in Current oncology (Toronto) (01.04.2015)
Get full text
Journal Article
121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study
Saavedra Serrano, C., Pérez Mies, B., Gion Cortes, M., Cortes Salgado, A., Fernández Abad, M., Martinez-Jañez, N., Soriano, M., Guerra, E.M., Miranda, E. Lopez
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
336TiP Ipatasertib plus non-taxane chemotherapy for metastatic triple-negative breast cancer (TNBC): Pathfinder trial
Llombart Cussac, A., Soberino, J., Gion, M., Bermejo, B., Martinez- Garcia, M., Braga, S., Cardoso, F., Vieira, C., Lopez-Miranda, E., Sampayo, M., Malfettone, A., Cortés, J., Pérez-Garcia, J.M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
271P Eribulin (E) plus endocrine therapy (ET) in patients (pts) with HR[+]/HER2[-] metastatic breast cancer (mBC) after progression on previous ET: The REVERT study
Lopez Gonzalez, A., Del Barco Berron, S., Garau Llinas, I., Galan Gramaje, M., Castelo, B., Cortes Salgado, A., Sanchez-Rovira, P., Martinez Bueno, A., García, A., Gener, P., Mina, L., Alcalá, D., Sampayo-Cordero, M., Cortés, J., Perez Garcia, J.M., Llombart Cussac, A., Lopez Miranda, E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
298P Differences in the mutational profile between primary breast carcinomas and their cutaneous metastasis
Martínez, S. González, Mies, B. Pérez, Casas, T. Caniego, Rosa, J.M. Rosa, Peralto, J.L. Rodríguez, Curigliano, G., Schmid, P., Kümmel, S., Garcia, J.M. Perez, Miranda, E. Lopez, Cortes, M. Gion, Calvo, J. Palacios, Cortés, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
188PEfficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience
Martin Huertas, R, Lopez Miranda, E, Corral de la Fuente, E, Serrano Domingo, J J, Fernandez Abad, M, Martinez, N, Guerra, E M, Cortes Salgado, A, Gion Cortes, M, Carrato Mena, A
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
562P Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex
Pedrazzoli, A.B. Azaro, Garcia, J.M. Perez, Cortés, J., Miranda, E. Lopez, Colombo, I., Garralda, E., Hess, D., Nuciforo, P.G., Vivancos, A., Ferrarotto, R., Schoenborn-Kellenberger, O., Jorga, K., Vigolo, M., Beni, L., Lehal, R., Murone, M., Bauer, M., Pisa, P., Vogl, F.D., Stathis, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis : a randomized double-blind study
DUENAS-GONZALEZ, A, SOBREVILLA-CALVO, P, FRIAS-MENDIVIL, M, GALLARDO-RINCON, D, LARA-MEDINA, F, AGUILAR-PONCE, L, MIRANDA-LOPEZ, E, ZINSER-SIERRA, J, REYNOSO-GOMEZ, E
Published in Bone marrow transplantation (Basingstoke) (01.05.1996)
Get full text
Published in Bone marrow transplantation (Basingstoke) (01.05.1996)
Journal Article
Abstract P5-21-01: Cobimetinib combined with paclitaxel as first-line treatment for patients with advanced triple-negative breast cancer (COLET study): Primary analysis of cohort I
Brufsky, A, Miles, D, Zvirbule, Z, Eniu, A, Lopez-Miranda, E, Seo, JH, Orditura, M, Le Du, F, Wongchenko, M, Poulin-Costello, M, Simmons, B, McNally, V, Loi, S, Kim, S-B
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
LBA23 ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2- ABC) with aggressive disease criteria
de la Haba Rodriguez, J., Cortés, J., Di Cosimo, S., Blancas López-Barajas, I., Cortez Castedo, S.P., López, A., López-Miranda, E., Pla Juher, H., Albacar Miro, C.R., Ponce, J., Carañana Ballerini, V., Paris Bouzas, L., Valero Arbizu, M., Ruiz Borrego, M.R.B., Iranzo, V., Garrido, A., Alcalá-López, D., Mina, L., Garcia Mosquera, J.J., Llombart Cussac, A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04
Santisteban, M, Casas, M, Bezares, S, Holgado, E, Palazón-Carrión, N, Alonso-Romero, JL, Benito, S, Henao, F, Jiménez-Cortegana, C, Chiesa, M, de la Cruz-Merino, L, Ceballos, I, Quiroga, V, Ramos, M, López-Miranda, E, Rodriguez, L. M, Moreno, F, Rojo, F, Cruz, J, Andrés, R, Puertes, A, Sánchez-Margalet, V, Gion, M, Caballero, R, Cortés, A, Soto, A, Cortés, J
Published in BMC cancer (03.12.2022)
Published in BMC cancer (03.12.2022)
Get full text
Journal Article
347PMulticenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study
López-Miranda, E, Di Cosimo, S, Brain, E, Ravnik, M, Escrivá-de-Romaní, S, Vidal, M, Gligorov, J, Borstnar, S, Calabuig, L, Sampayo, M, Pérez-García, J M, Riva, F, Malfettone, A, Llombart Cussac, A, Suter, T, Cortés, J
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study
López-Miranda, E., Di Cosimo, S., Brain, E., Ravnik, M., Escrivá-de-Romaní, S., Vidal, M., Gligorov, J., Borstnar, S., Calabuig, L., Sampayo, M., Pérez-García, J.M., Riva, F., Malfettone, A., Llombart Cussac, A., Suter, T., Cortés, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
347P - Multicenter phase I trial of trastuzumab emtansine (T-DM1) in combination with non-pegylated liposomal doxorubicin (NPLD) in HER2[+] metastatic breast cancer (MBC). THELMA study
López-Miranda, E., Di Cosimo, S., Brain, E., Ravnik, M., Escrivá-de-Romaní, S., Vidal, M., Gligorov, J., Borstnar, S., Calabuig, L., Sampayo, M., Pérez-García, J.M., Riva, F., Malfettone, A., Llombart Cussac, A., Suter, T., Cortés, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Abstract OT1-02-03: Phase I multicenter clinical trial evaluating the combination of trastuzumab emtansine (T-DM1) and non-pegylated liposomal doxorubicin (NPLD) in HER2-positive metastatic breast cancer (MBC) (MEDOPP038 study)
López-Miranda, E, Brain, E, Saura, C, Gligorov, J, Dubot, C, Dieras, V, Suter, TM, Aguirre, E, Perez-García, JM, Llombart, A, Cortés, J
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study
Alés-Martínez, J.E., Morales, S., Fernández Abad, M., Sánchez-Rovira, P., Salvador Bofill, F.J., Lahuerta, A., García-Sáenz, J.A., Garau Llinas, I., Díaz Redondo, T., Ferrer, N., Carañana, V., López, R., Alonso Soler, S.E., Bermejo, B., de la Haba, J., Zamora, P., Balmana, J., López-Miranda, E., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
384TiP - Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study
Alés-Martínez, J.E., Morales, S., Fernández Abad, M., Sánchez-Rovira, P., Salvador Bofill, F.J., Lahuerta, A., García-Sáenz, J.A., Garau Llinas, I., Díaz Redondo, T., Ferrer, N., Carañana, V., López, R., Alonso Soler, S.E., Bermejo, B., de la Haba, J., Zamora, P., Balmana, J., López-Miranda, E., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article